How to build a winning medicine?

Only accessible with Full Day tickets.
Not accessible for Morning + Lunch tickets.

How to build a winning medicine?

A new medicine wins because it is better, faster, scalable and strong enough to beat what the rest of the world is building at the same time.

Drawing on decades of experience at the highest level of pharma and biotech, Paul Stoffels will take us behind the scenes of what it really takes to turn scientific breakthroughs into medicines that can change the standard of care.

Through concrete examples, from the transformation of HIV treatment and the unprecedented speed of COVID vaccine development to radically shorter clinical development timelines, he will show why great science alone is not enough. Speed, capital, regulation, operational excellence and the ability to think long term all play a decisive role.

And that raises a bigger question for Belgium and Europe. While other regions are accelerating drug development, investment and approval processes, can Europe still create the conditions for world-class life sciences innovation to thrive and compete?

After the keynote, Paul Stoffels will be joined by Peter Verhaeghe (former Chair of argenx), Fiona du Monceau (UCB) and Patrick Chaltin (CD3) for a discussion on Europe’s competitiveness in life sciences.

Together, they bring perspectives from across the drug development journey: turning academic discoveries into promising drug candidates, building and financing biotech companies, developing medicines and bringing them to patients worldwide.

Where is Europe getting it right? Where are we losing ground? And what needs to change if we want to develop the next generation of breakthrough medicines here, rather than watching others take the lead?

Only accessible with Full Day tickets.
Not accessible for Morning + Lunch tickets.